申请人:Giblin Gerard Martin Paul
公开号:US20080275053A1
公开(公告)日:2008-11-06
Compounds of formula (I) or a pharmaceutically acceptable derivative thereof:
wherein A, B, D, Z, R
1
, R
2a
, R
2b
, and R
x
are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.
公式(I)的化合物或其药学上可接受的衍生物:
其中A、B、D、Z、R1、R2a、R2b和Rx的定义如规范所述,一种制备这种化合物的方法,包含这种化合物的药物组合物以及这种化合物在医学上的用途。